SCHEMBL7119836

SCHEMBL7119836

O=C(O)Oc1c(Br)cc(Br)cc1Br

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 1/20 0.52
▸ AKR1C4 P17516 1/20 0.43
▸ AKR1C3 P42330 1/20 0.43
▸ AKR1C2 P52895 1/20 0.43
▸ AKR1C1 Q04828 1/20 0.43
▸ CYP3A4 P08684 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ ALOX15 P16050 4/20 0.37
▸ ALOX12 P18054 3/20 0.37
▸ TPMT P51580 1/20 0.37
▸ AKR1B1 P15121 2/20 0.36
▸ THRB P10828 2/20 0.36
▸ GABRA1 P14867 1/20 0.36
▸ GABRB1 P18505 1/20 0.36
▸ GABRA2 P47869 1/20 0.36
▸ GABRB2 P47870 1/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ ERN1 O75460 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5704226 0.83 HSD17B10 (0.48) HSD17B10AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL23855075 0.83 HSD17B10 (0.48) HSD17B10AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL9670424 0.81 HSD17B10 (0.47) HSD17B10AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL4647729 0.79 HSD17B10 (0.50) HSD17B10AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL4644330 0.79 HSD17B10 (0.46) HSD17B10AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL581551 0.79 HSD17B10 (0.46) HSD17B10AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL28337678 0.76 PRNP (0.36) HSD17B10MEN1KMT2ALMNAMAPT
SCHEMBL10782614 0.76 ALOX15 (0.47) HSD17B10AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL9174491 0.76 HSD17B10 (0.43) HSD17B10AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL4641891 0.76 HSD17B10 (0.43) HSD17B10AKR1C4AKR1C3AKR1C2AKR1C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6576739-B2 Conversion of the hindered bisphenol to the corresponding bischloroformate and subsequent treatment with an amine catalyst and an aqueous base to effect polymerization by hydrolysis and condenstation of bischloroformate groups GENERAL ELECTRIC COMPANY 2003-06-10 — — US claimed
US-20020111456-A1 Method of polycarbonate preparation SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2002-08-15 — — US claimed
WO-2001085825-A2 METHOD OF POLYCARBONATE PREPARATION GENERAL ELECTRIC COMPANY (US) 2001-11-15 — — WO claimed
CN-119241661-A Cyclic peptide compound with anti-inflammatory effect and preparation method and application thereof 云南贝泰妮生物科技集团股份有限公司 2025-01-03 — — CN disclosed
US-5155113-A Administering 5-fluorouracil and derivatives with pyridine and pyridone derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-10-13 — — US disclosed
EP-0180188-B1 A COMPOSITION FOR INCREASING THE ANTI-CANCER ACTIVITY OF AN ANTI-CANCER COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-04-15 — — EP disclosed
US-4714729-A THERMOPLASTIC RESINS AND UNSYMMETRICAL HALOGENATED CARBONATE AND/OR UNSYMMETRICAL HALOGENATED ETHER THE DOW CHEMICAL COMPANY (US) 1987-12-22 — — US disclosed
EP-0180188-A2 A composition for increasing the anti-cancer activity of an anti-cancer compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-07 — — EP disclosed
Send feedback